Barriers, potential solutions, and alternatives to randomized clinical trials in male reproductive medicine

Inklings
Barriers, potential solutions, and alternatives to randomized clinical trials in male reproductive medicine
Like

Volume 111, Issue 5, Pages 871–872

Authors:

Joshua A. Halpern, M.D., M.S., Robert E. Brannigan, M.D.

Abstract:

The field of reproductive medicine is enjoying a renaissance in advancement and innovation, as the evolution of laboratory techniques, genetic medicine, and assisted reproductive technologies (ART) have dramatically enhanced the quality of care and outcomes for patients with subfertility. From microfluidics to home semen testing, invention has rendered this an exciting time in the study of male reproductive medicine. Yet as pioneers continue to push the envelope, there remains an incomplete trail of evidence, hampering our ability to utilize these advancements in a way that will optimally serve our patients. The pace of innovation has surpassed our ability to consistently provide robust evidence for its implementation.


Read the full text here.


Please sign in or register for FREE

Your Fertility and Sterility Dialog login information is not the same as your ASRM or EES credentials. Users must create a separate account to comment or interact on the Dialog.